EcoR1 Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,049,405
Closed -$5.03M 52
2024
Q4
$5.03M Buy
+3,049,405
New +$7.68M 0.2% 44
2020
Q3
Sell
-619,855
Closed -$21.3M 56
2020
Q2
$21.3M Sell
619,855
-1,722,020
-74% -$51.3M 1.59% 20
2020
Q1
$52M Buy
2,341,875
+1,890,521
+419% +$47.8M 5.43% 5
2019
Q4
$8.83M Buy
+451,354
New +$7.17M 0.84% 27
2017
Q4
Sell
-2,262,678
Closed -$8.96M 35
2017
Q3
$8.96M Sell
2,262,678
-274,348
-11% -$933K 1.23% 22
2017
Q2
$8.22M Hold
2,537,026
1.9% 16
2017
Q1
$11.5M Buy
+2,537,026
New +$9.28M 3.2% 11
2016
Q4
Sell
-590,527
Closed -$1.84M 35
2016
Q3
$1.84M Buy
+590,527
New +$1.43M 0.7% 28

Other funds holding FATE